Why are kids with lupus at an increased risk of cardiovascular disease?

Area of Science:

• Autoimmune diseases
• Pediatric rheumatology
• Cardiovascular health

Background:

• Juvenile-onset systemic lupus erythematosus (SLE) is a severe autoimmune condition affecting multiple organs.
• Children with SLE experience poorer prognoses than adults, marked by aggressive disease, higher rates of lupus nephritis, and increased cardiovascular disease (CVD) risk.
• Emerging evidence highlights a significant, often underrecognized, risk of CVD in pediatric SLE.

Purpose of the Study:

• To review the current evidence linking SLE in children to an increased risk of cardiovascular disease (CVD).
• To explore the underlying mechanisms (pathogenesis) contributing to CVD in juvenile SLE.
• To outline a clinical strategy for managing and mitigating CVD risk in this vulnerable population.

Main Methods:

• Systematic literature review of studies on juvenile-onset SLE and cardiovascular disease.
• Analysis of epidemiological data and clinical trial outcomes.
• Synthesis of research on the pathophysiology of SLE-related CVD.

Main Results:

• Children with SLE exhibit a demonstrably higher incidence of cardiovascular complications compared to the general pediatric population.
• Specific autoimmune pathways and inflammatory markers in SLE contribute to accelerated atherosclerosis and other CVD risk factors.
• Early identification and aggressive management of traditional and SLE-specific CVD risk factors are crucial.

Conclusions:

• Juvenile-onset SLE confers a substantial and elevated risk for cardiovascular disease (CVD) that requires dedicated clinical attention.
• Understanding the pathogenesis of CVD in pediatric SLE is key to developing targeted preventive and therapeutic strategies.
• Proactive cardiovascular risk management should be an integral component of comprehensive care for children with SLE.